These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Author: Belch JJ, McKay A, McArdle B, Leiberman P, Pollock JG, Lowe GD, Forbes CD, Prentice CR.
    Journal: Lancet; 1983 Feb 12; 1(8320):315-7. PubMed ID: 6130330.
    Abstract:
    A 96 h infusion of epoprostenol (prostacyclin) or placebo was given as a treatment for rest pain to 28 patients with severe peripheral arterial disease. 24 h after the end of the infusion patients given epoprostenol had significantly less pain and took fewer analgesics tablets than did the controls. In some patients the epoprostenol effect lasted for over 1 month.
    [Abstract] [Full Text] [Related] [New Search]